FDA Open To Industry Input On Separate IVD Least Burdensome Guidance
This article was originally published in The Gray Sheet
Executive Summary
Industry recommendations on in vitro diagnostic sample data requirements will help FDA develop a separate least burdensome guidance on IVD products, CDRH Office of Device Evaluation Director Susan Alpert stated.